<?xml version="1.0" encoding="UTF-8"?>
<ref id="B35-vaccines-07-00174">
 <label>35.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Paillot</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Rash</surname>
    <given-names>N.L.</given-names>
   </name>
   <name>
    <surname>Garrett</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Prowse-Davis</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Montesso</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Cullinane</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Lemaitre</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Thibault</surname>
    <given-names>J.C.</given-names>
   </name>
   <name>
    <surname>Wittreck</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Dancer</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>How to meet the last oie expert surveillance panel recommendations on equine influenza (ei) vaccine composition: A review of the process required for the recombinant canarypox-based ei vaccine</article-title>
  <source>Pathogens</source>
  <year>2016</year>
  <volume>5</volume>
  <elocation-id>64</elocation-id>
  <pub-id pub-id-type="doi">10.3390/pathogens5040064</pub-id>
 </element-citation>
</ref>
